When your MedTech launch has several weak points, how do you know which one to fix first before you waste 90 days improving the wrong thing?MedTech founders rarely fail because the device is poor. More often, they stall because they improve the wrong part of their launch first. When product, proof, pathway, and people all have room for improvement, deciding where to focus becomes critical. In this episode, Hakeem breaks down a practical decision rule that helps you identify the one move most likely to unlock real contracts and meaningful revenue.By listening, you’ll:Learn why the lowest-scoring weakness is not always the first problem you should solveUnderstand how commercial conversations reveal whether proof, pathway, or people is the real revenue constraintUse a simple 90-day decision filter to prioritize the move most likely to accelerate traction this quarterPress play now to identify the one change that can move your MedTech launch closer to real contracts and meaningful revenueBook a 30min Healthcare Export Accelerator discovery callMessage me via DM on LinkedinThis podcast is for clinicians turning medical devices into real businesses, with practical insight on go to market strategy, exporting, and scaling in international MedTech.